
In this presentation, Sofia Tapani explores the transformative journey of Statisticians and Data Scientists in the age of AI and Automation. Drawing from her own evolution—from a hands-on coder to a strategic leader in drug development—Sofia illustrates how Statisticians are no longer just technical experts but central drivers of innovation, quality, and decision-making in modern medicine.
Key themes include:
This session will inspire attendees to rethink their role—not just as analysts, but as strategic catalysts in the AI-powered transformation of healthcare.
Sofia Tapani (PhD) is Executive Director of Statistics at AstraZeneca, leading strategic initiatives that advance the role of quantitative science in drug development. With a background in mathematics and biostatistics and a commitment to modernizing evidence generation, she champions the integration of advanced analytics and AI to improve decision‑making across clinical programs. Sofia is recognized for her contributions to industry thought leadership on the evolving role of statisticians in an AI‑driven future. She is passionate about fostering collaboration between statisticians, data scientists, and cross‑functional partners to accelerate impactful innovation.